Teacher Retirement System of Texas increased its holdings in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 18.5% ...

Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...

Company to Host Conference Call Today, March 27, at 4:30pm ETBOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and ...

In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.

Lucia Notterpek, Ph.D., professor and senior associate dean for research at the University of Nevada, Reno School of Medicine ...

McDonald Criteria revisions around 30% of patients with atypical clinical symptoms or radiological-only presentation meet MS ...

Aqemia announces it is broadening and accelerating its computational platform to target RNAs using its physics-enabled generative AI engine. Building on successes in epitranscriptomics, Aqemia aims to ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness ...

Bollywood star Salman Khan opens up about his battle with trigeminal neuralgia also known as the suicide disease Learn about ...

Dimika V. Cavalier shares details of her long MS diagnosis journey and the eventual acceptance of her new normal.

Bollywood superstar Salman Khan revealed his battle with trigeminal neuralgia, a severe facial nerve disorder often called the "suicide disease" due to its extreme pain. The condition affects the ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...